Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
life sciences
3
×
national blog main
san diego blog main
san diego top stories
boston blog main
boston top stories
clinical trials
fda
national top stories
new york blog main
new york top stories
proteon therapeutics
san francisco blog main
san francisco top stories
startups
3b pharmaceuticals
abeona therapeutics
acetylon pharmaceuticals
acute myeloid leukemia
adicet bio
aegerion pharmaceuticals
akcea therapeutics
alkermes
allan kaspar
altria
ambys medicines
amgen
amphivena therapeutics
amryt pharma
andrew komjathy
aron knickerbocker
artara therapeutics
avexis
bial
biontech
boulder/denver blog main
boulder/denver top stories
brian johns
brian kaspar
What
control
3
×
biotech
disease
according
add
aiming
akcea
ambys
big
called
carbidopa
cases
centers
cigarettes
combination
daily
deadly
deal
deaths
debuted
diseases
electronic
experience
fda
formed
future
gets
including
injuries
launch
levodopa
linked
liver
lung
make
medication
medicines
nash
neurocrine
new
Language
unset
Current search:
control
×
biotech
×
" life sciences "
×
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
